Erik P Sulman
Erik P Sulman
Professor and Vice-Chair of Radiation Oncology, NYU Langone Health
Подтвержден адрес электронной почты в домене nyulangone.org - Главная страница
Название
Процитировано
Процитировано
Год
Identification of a CpG island methylator phenotype that defines a distinct subgroup of glioma
H Noushmehr, DJ Weisenberger, K Diefes, HS Phillips, K Pujara, ...
Cancer cell 17 (5), 510-522, 2010
22252010
A randomized trial of bevacizumab for newly diagnosed glioblastoma
MR Gilbert, JJ Dignam, TS Armstrong, JS Wefel, DT Blumenthal, ...
New England Journal of Medicine 370 (8), 699-708, 2014
21502014
The transcriptional network for mesenchymal transformation of brain tumours
MS Carro, WK Lim, MJ Alvarez, RJ Bollo, X Zhao, EY Snyder, EP Sulman, ...
Nature 463 (7279), 318-325, 2010
11162010
Mesenchymal differentiation mediated by NF-κB promotes radiation resistance in glioblastoma
KPL Bhat, V Balasubramaniyan, B Vaillant, R Ezhilarasan, K Hummelink, ...
Cancer cell 24 (3), 331-346, 2013
7362013
Tumor evolution of glioma-intrinsic gene expression subtypes associates with immunological changes in the microenvironment
Q Wang, B Hu, X Hu, H Kim, M Squatrito, L Scarpace, AC deCarvalho, ...
Cancer cell 32 (1), 42-56. e6, 2017
7102017
m6A demethylase ALKBH5 maintains tumorigenicity of glioblastoma stem-like cells by sustaining FOXM1 expression and cell proliferation program
S Zhang, BS Zhao, A Zhou, K Lin, S Zheng, Z Lu, Y Chen, EP Sulman, ...
Cancer cell 31 (4), 591-606. e6, 2017
6792017
Phase II trial of erlotinib plus concurrent whole-brain radiation therapy for patients with brain metastases from non–small-cell lung cancer
JW Welsh, R Komaki, A Amini, MF Munsell, W Unger, PK Allen, JY Chang, ...
Journal of Clinical Oncology 31 (7), 895, 2013
4342013
Epidermal growth factor receptor variant III status defines clinically distinct subtypes of glioblastoma
CE Pelloski, KV Ballman, AF Furth, L Zhang, E Lin, EP Sulman, K Bhat, ...
Journal of Clinical Oncology 25 (16), 2288-2294, 2007
3552007
A multigene predictor of outcome in glioblastoma
H Colman, L Zhang, EP Sulman, JM McDonald, NL Shooshtari, A Rivera, ...
Neuro-oncology 12 (1), 49-57, 2010
3522010
MGMT promoter methylation is predictive of response to radiotherapy and prognostic in the absence of adjuvant alkylating chemotherapy for glioblastoma
AL Rivera, CE Pelloski, MR Gilbert, H Colman, C De La Cruz, EP Sulman, ...
Neuro-oncology 12 (2), 116-121, 2010
3462010
Post-operative stereotactic radiosurgery versus observation for completely resected brain metastases: a single-centre, randomised, controlled, phase 3 trial
A Mahajan, S Ahmed, MF McAleer, JS Weinberg, J Li, P Brown, S Settle, ...
The lancet oncology 18 (8), 1040-1048, 2017
3442017
IDH1 mutant malignant astrocytomas are more amenable to surgical resection and have a survival benefit associated with maximal surgical resection
J Beiko, D Suki, KR Hess, BD Fox, V Cheung, M Cabral, N Shonka, ...
Neuro-oncology 16 (1), 81-91, 2014
3382014
The transcriptional coactivator TAZ regulates mesenchymal differentiation in malignant glioma
KPL Bhat, KL Salazar, V Balasubramaniyan, K Wani, L Heathcock, ...
Genes & development 25 (24), 2594-2609, 2011
3182011
A region of consistent deletion in neuroblastoma maps within human chromosome 1p36. 2-36.3
PS White, JM Maris, C Beltinger, E Sulman, HN Marshall, M Fujimori, ...
Proceedings of the National Academy of Sciences 92 (12), 5520-5524, 1995
3041995
IDH mutation status and role of WHO grade and mitotic index in overall survival in grade II–III diffuse gliomas
A Olar, KM Wani, KD Alfaro-Munoz, LE Heathcock, HF van Thuijl, ...
Acta neuropathologica 129 (4), 585-596, 2015
2552015
Glioblastoma-infiltrated innate immune cells resemble M0 macrophage phenotype
K Gabrusiewicz, B Rodriguez, J Wei, Y Hashimoto, LM Healy, SN Maiti, ...
JCI insight 1 (2), 2016
2412016
IMRT reirradiation of head and neck cancer—disease control and morbidity outcomes
EP Sulman, DL Schwartz, TT Le, KK Ang, WH Morrison, DI Rosenthal, ...
International Journal of Radiation Oncology* Biology* Physics 73 (2), 399-409, 2009
2282009
TERT promoter mutations and risk of recurrence in meningioma
F Sahm, D Schrimpf, A Olar, C Koelsche, D Reuss, J Bissel, A Kratz, ...
JNCI: Journal of the National Cancer Institute 108 (5), 2016
1992016
Loss of heterozygosity at 1p36 independently predicts for disease progression but not decreased overall survival probability in neuroblastoma patients: a Children’s Cancer …
JM Maris, MJ Weiss, C Guo, RB Gerbing, DO Stram, PS White, ...
Journal of clinical oncology 18 (9), 1888-1899, 2000
1912000
Significance of chromosome 1p loss of heterozygosity in neuroblastoma
JM Maris, PS White, CP Beltinger, EP Sulman, RP Castleberry, JJ Shuster, ...
Cancer research 55 (20), 4664-4669, 1995
1911995
В данный момент система не может выполнить эту операцию. Повторите попытку позднее.
Статьи 1–20